USE OF CASD1 AS A BIOMARKER OF A CANCER EXPRESSING THE O-ACETYLATED-GD2 GANGLIOSIDE Application WO-2022258834-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022